Figure 3a. Average expression of each gene in the CD19+ and CD19? subpopulations isolated from the tumor-biopsy specimens for immune response 1

TABLE I. Representative genes from each cluster N.D.  not done in this study; ISH  in situ hybridization

Table 2. Genes correlated with the LMP-G1 and G2?G3 distinction

Supplementary Figure 1a Complete list of genes in signature set for lymph node metastasis in head and neck squamous cell carcinoma

Supplementary Figure 1b Complete list of genes in signature set for lymph node metastasis in head and neck squamous cell carcinoma

Supplemental Table 2. 100 genes up & down-regulated 2 fold for WT-d2-promyelocytes vs. PR-d2-promyelocytes

Supplemental Table 5a: Sixty-two distinguishing genes for PR versus PR+RP versus PR+XRT APL samples.

Supplemental Table 5b: Sixty-two distinguishing genes for PR versus PR+RP versus PR+XRT APL samples.

Supplemental Table 3: Sixty-five distinguishing genes for PR versus PR_RP APL samples.

Supplemental Table 4: Eighty-five distinguishing genes for PR versus PR+XRT APL samples.

Table 1 List of motility-related genes differentially expressed in the invasive subpopulation of tumor cells

Table 2 Genes differentially expressed in invasive cells identified in this study showing the same pattern of expression in cell lines and metastatic tumors derived from them

Table 3 Predicted membrane-associated and secreted genes in a breast cancer expression dataset (see text for details)

Table 1. The top 27 unique genes with highest signal-to-noise ratios

TABLE 2. Candidate Expression Markers of Cardiac Allograft Rejection. 40 probe IDs (30 genes) that are altered in acute cellular rejection and returned toward normal in response to augmented immunosuppression. Genes identified in RNA extracted from blood samples obtained during during endomyocardial biopsy from  a cohort of 189 cardiac transplant patients.

Table 1. Differentially expressed genes in breast and ovarian cancers analysed by cancer profiling array

Table 2 Hormones  growth factors and receptors showing 8-fold or greater change in mRNA expression between the tumor and normal breast tissue